Vancouver, BC -- (SBWIRE) -- 12/22/2020 -- Nanopharmaceutical Drugs Market

The global nanopharmaceutical drugs market size is forecasted to reach a value of USD 82.71 Billion by 2027 at a CAGR of 7.3% according to an analysis by Emergen Research.  The nanopharmaceutical drugs market is observing high demand attributed to its increasing application in oncology, cardiovascular, immunology, neurology, and anti-biotic. Factors such as the rising incidence of cancer, increased investments, and technological advancements in disease diagnostic procedures will drive the market growth during the forecast period.

Key participants include Amgen Inc., AstraZeneca PLC, Gilead Sciences Inc., Novartis AG, F. Hoffmann-La Roche AG, AbbVie Inc., Johnson & Johnson, Pfizer Inc., Sanofi SA, and Merck & Co. Inc., among others.

Download Free Sample PDF Copy at https://www.emergenresearch.com/request-sample-form/378

Market Drivers

The microemulsion is likely to grow at the fastest rate of 8.3% of the nanopharmaceutical drugs market during the forecast period. Microemulsions have gained importance as these reduce drug toxicity and increase clinical potency. The application of nanopharmaceutical drugs in oncology accounted for the largest market share of over 36.0% in 2019. By distribution channel, hospital pharmacies accounted for the largest market share of over 57.0% of the nanopharmaceutical drugs market in 2019. The increased purchasing power of the people has led to an increase in the number of hospitals and pharmacies, globally, which has encouraged the growth of the nanopharmaceutical drugs market.

Type Outlook (Revenue, USD Billion; 2017-2027)
Liposomes
Polymeric Micelles
Microemulsion
Solid Lipid Nanoparticles
Nanoemulsion
Others

Application Outlook (Revenue, USD Billion; 2017-2027)
Oncology
Cardiovascular/Physiology
Anti-inflammatory/Immunology
Neurology
Anti-Infective
Others

Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)
Hospital Pharmacies
Retail Off-Line Pharmacies
Retail On-Line Pharmacies

Regional Analysis

The North American region held the highest market share of 47.2%  of the nanopharmaceutical drugs market in the year 2019, owing to the highly developed healthcare services in the region. However, the Asia Pacific region is forecast to grow at the fastest CAGR during the forecast period, owing to the fast-developing healthcare sector and the expected growth in the number of super-speciality clinics in the region.

ORDER NOW (Customized Report Delivered as per Your Specific Requirement) @ https://www.emergenresearch.com/select-license/378

Table of Content

Chapter 1. Methodology & Sources

    1.1. Market Definition

    1.2. Research Scope

    1.3. Methodology

    1.4. Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

    1.5. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Nanopharmaceutical Drugs Market Segmentation & Impact Analysis

    4.1. Nanopharmaceutical Drugs Market Material Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers analysis

                    4.2.2.1. Rising incidence of cancer

                    4.2.2.2. Growing geriatric population

                    4.2.2.3. Increased investments in R&D activities

                    4.2.2.4. Technological advancements in disease diagnostic procedures

          4.2.3. Market restraints analysis

                    4.2.3.1. Cost-prohibitive nanopharmaceutical drug discovery

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. Porter's Five Forces Analysis

    4.6. Competitive Metric Space Analysis

    4.7. Price trend Analysis

    4.8. Covid-19 Impact Analysis

Chapter 5. Nanopharmaceutical Drugs Market By Type Insights & Trends, Revenue (USD Million) 

    5.1. Type Dynamics & Market Share, 2019 & 2027

          5.1.1. Liposomes

          5.1.2. Polymeric Micelles

          5.1.3. Microemulsion

          5.1.4. Solid Lipid Nanoparticles

          5.1.5. Nanoemulsion

          5.1.6. Others

Chapter 6. Nanopharmaceutical Drugs Market By Application Insights & Trends Revenue (USD Million) 

    6.1. Application Dynamics & Market Share, 2019 & 2027

          6.1.1. Oncology

          6.1.2. Cardiovascular/Physiology

          6.1.3. Anti-inflammatory/Immunology

          6.1.4. Neurology

          6.1.5. Anti-Infective

          6.1.6. Others

          6.1.7. Others

Chapter 7. Nanopharmaceutical Drugs Market By Distribution Channel Insights & Trends Revenue (USD Million) 

    7.1. Distribution Channel Dynamics & Market Share, 2019 & 2027

          7.1.1. Hospital Pharmacies

          7.1.2. Retail Off-Line Pharmacies

          7.1.3. Retail On-Line Pharmacies

To be continued…!
Take a Look at our Related Reports:

Bioremediation Market Projected To Be Worth USD 334.70 Billion By 2027 Growing at a CAGR of 15.5% | Emergen Research

Cancer Imaging Systems Market To Reach USD 12.24 Billion by 2027 | Emergen Research

Embedded SIM (eSIM) Market Size To Be USD 3019.1 Million by 2027 | Emergen Research

AI-Enabled Medical Imaging Solutions Market Size To Be Worth USD 4,720.6 Million by 2027 | Emergen Research

Intelligent Drug Discovery Market Size To Be Worth USD 3,711.8 Million by 2027 | Emergen Research

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-nanopharmaceutical-drugs-market